Dow Chemical beats estimates amid sales gains across businesses


Dow Chemical (NYSE:DOW) +1.2% premarket after Q2 results rose a better than expected 3% as the company reported growth in all its operating segments; earnings tumbled 60% Y/Y on higher sales costs and an unfavorable comparison with the year-earlier period, but results beat analyst estimates.

Q2 sales growth was led by the electronic and functional materials segment, which reported a 5% increase in revenue to $1.2B; sales in performance plastics rose ~2% to $3.75B, while coatings and infrastructure solutions rose ~3% to $1.95B and agricultural sciences also added ~3% to $1.91B.

Margins improved due to higher prices and a tight control on costs, and rose in four of Dow's six units; the exceptions were the agriculture business and the feedstocks and energy division.

From other sites
Comments (1)
  • salvatort
    , contributor
    Comments (411) | Send Message
     
    Adjusting EPS, excluding one-time items, were actually up 16% Y/Y.
    23 Jul 2014, 09:06 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs